The E3 ubiquitin ligase PDZRN3 targets Gsα for K27-linked polyubiquitination and proteasomal degradation in breast cancer
Journal of Biological Chemistry · 2026-11 · 113767
DOI: 10.1016/j.jbc.2026.113767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-11. Verfasst von Hai-Yan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer remains the most prevalent malignancy and a leading cause of cancer-related mortality among women globally. Although PDZRN3 has been implicated in the pathogenesis of several cancers, its specific function and underlying mechanisms in breast cancer remain poorly understood. In this study, we demonstrated that downregulation of PDZRN3 expression in breast cancer tissues is associated with promoter hypermethylation. Additionally, GNAS-encoding the G protein α subunit (Gsα)-acts as a proto-oncogene in multiple tumor types, where its aberrant activation drives oncogenic signaling and tumor progression. Here, we identify PDZRN3 as a direct binding partner of GNAS and further establish its role as an E3 ubiquitin ligase that promotes K27-linked polyubiquitination of GNAS, thereby targeting it for proteasomal degradation. This PDZRN3-mediated degradation attenuates the activation of the downstream PI3K-AKT signaling pathway, a key driver of breast cancer progression. Our findings establish PDZRN3 as a critical tumor suppressor in breast carcinogenesis, unveiling a previously unrecognized regulatory axis with potential therapeutic implications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China. Electronic address: mhytmu@126.com.
- Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Graduate School, Wannan Medical Universi…
- Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China; Graduate School, Bengbu Medical Universi…
- the First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; Key Laboratory of Cancer Prevention and Therapy, Tian…
- Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China. Electronic address: jingwang0909@163.com.
- Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China. Electronic address: xiaopengma@fsyy.ustc…
Zitieren
APA
Ma, H. Y., Chu, Y. P., Sun, D. C., Wang, X., Wang, J., Ma, X. P., & Zhang, D. (2026). The E3 ubiquitin ligase PDZRN3 targets Gsα for K27-linked polyubiquitination and proteasomal degradation in breast cancer. Journal of Biological Chemistry, 113767. https://doi.org/10.1016/j.jbc.2026.113767
Vancouver
Ma HY, Chu YP, Sun DC, Wang X, Wang J, Ma XP, et al. The E3 ubiquitin ligase PDZRN3 targets Gsα for K27-linked polyubiquitination and proteasomal degradation in breast cancer. Journal of Biological Chemistry. 2026:113767. doi:10.1016/j.jbc.2026.113767
BibTeX
@article{Ma2026,
author = {Ma, Hai-Yan and Chu, Yi-Ping and Sun, Di-Chen and Wang, Xin and Wang, Jing and Ma, Xiao-Peng and Zhang, Di},
title = {The E3 ubiquitin ligase PDZRN3 targets Gsα for K27-linked polyubiquitination and proteasomal degradation in breast cancer},
journal = {Journal of Biological Chemistry},
year = {2026},
pages = {113767},
doi = {10.1016/j.jbc.2026.113767}
}
EUVIMED